title: Somatostatin analogue treatment for malignant hypercalcaemia.
authors.affiliation: Department of Clinical Oncology, Hammersmith Hospital, London.
authors.forename: M
authors.initials: M
authors.lastname: Harrison
authors.forename: N
authors.initials: N
authors.lastname: James
authors.forename: K
authors.initials: K
authors.lastname: Broadley
authors.forename: S R
authors.initials: SR
authors.lastname: Bloom
authors.forename: R
authors.initials: R
authors.lastname: Armour
authors.forename: S
authors.initials: S
authors.lastname: Wimalawansa
authors.forename: D
authors.initials: D
authors.lastname: Heath
authors.forename: J
authors.initials: J
authors.lastname: Waxman
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000150:complications; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010673:Pheochromocytoma / Q000150:complications
chemical_list: D015282:Octreotide